ketorolac
ketorolac: sourced relationships with 1 company · 9 clinical trials tracked · 1 FDA decision.
ketorolac evidence translation
What we can confirm
1 FDA record · 9 tracked trials
What it means
What to watch
Prepared research question
How could ketorolac → ABBV affect its developer, and what evidence supports the link?
Traceable citations · Unknowns marked
See linked entities and source evidence4 indications · 0 study sponsors
Related indications
Study sponsors
No additional listed-company sponsor is linked.
Dated Pipeline Records (1)
| Company | Dated record stage |
|---|---|
| AbbVie Inc. (ABBV) Reported 2009-07-22 · Current development: unknownSource | Approved |
Clinical Trial Registry Records (9)
Postoperative Pain Outcomes After Use of Bupivacaine-Meloxicam Extended-Release Solution in Robot Assisted Total Knee Arthroplasty: A Prospective Study
Primary endpoint: Amount of opioid medications used (measured in morphine milligrams equivalents)
Optimizing Pain Treatment in Children On Mechanical Ventilation
Primary endpoint: Acute Pain Episodes
Efficacy of Ropivacaine Epinephrine Clonidine Ketorolac (R.E.C.K) vs Exparel in Robotic Nephrectomy: a Randomized, Prospective Trial
Primary endpoint: Area Under the Curve (AUC) of the Numeric Rating Scale (NRS) pain intensity scores through 7 days (168 hours) for participants receiving Exparel vs. R.E.C.K.
Low-Dose Short-Term Ketorolac to Reduce Chronic Opioid Use in Orthopaedic Polytrauma Patients
Primary endpoint: Chronic Opioid Use
Efficacy of Nasal Migraine Cocktail Used In Pediatric Emergency Department: A Clinical Trial
Primary endpoint: Change from baseline in pain on the 10 point Faces Pain Scale-Revised in 2 hours
NSAID Injection Versus Corticosteroid Injection for Basilar Thumb Arthritis: A Randomized, Controlled Trial
Primary endpoint: Visual Analogue Scale (VAS) of Pain
Multimodal Nonopioid Pain Protocol Following Shoulder Arthroplasty Surgery
Primary endpoint: Pain Levels
INflammatory MediatorS in the PathophysIology of Diabetic REtinopathy (INSPIRE) Study
Primary endpoint: PGE2 level during Diabetic Retinopathy progression
A Phase 2, Open-Label Study of HTX 011 in a Multimodal Analgesic Regimen for Decreased Opioid Use Following Unilateral Open Inguinal Herniorrhaphy
Primary endpoint: Percentage of Subjects Receiving no Opioid Rescue
FDA Decisions1 records
Frequently asked questions
Which companies have sourced relationships with ketorolac?
ketorolac has dated SEC/FDA relationship records for AbbVie Inc..
How many clinical trials involve ketorolac?
BioSniper tracks 9 clinical trials involving ketorolac.
What is ketorolac's latest FDA decision?
The most recent tracked FDA decision for ketorolac is Approval, dated July 22, 2009.